These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8275488)

  • 41. Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas.
    Medeiros AC; Nagai MA; Neto MM; Brentani RR
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):331-3. PubMed ID: 8061582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
    Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
    Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interest of investigating p53 status in breast cancer by four different methods.
    Thirion A; Rouanet P; Thezenas S; Detournay D; Grenier J; Lopez-Crapez E
    Oncol Rep; 2002; 9(6):1167-72. PubMed ID: 12375013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
    Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
    Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletion of two separate regions on chromosome 3p in breast cancers.
    Chen LC; Matsumura K; Deng G; Kurisu W; Ljung BM; Lerman MI; Waldman FM; Smith HS
    Cancer Res; 1994 Jun; 54(11):3021-4. PubMed ID: 7910519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
    Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
    Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer.
    Yaremko ML; Kutza C; Lyzak J; Mick R; Recant WM; Westbrook CA
    Genes Chromosomes Cancer; 1996 Jul; 16(3):189-95. PubMed ID: 8814452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
    Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
    Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Molecular analysis of breast cancers: recent developments].
    Bièche I; Lidereau R
    Bull Cancer; 1992; 79(12):1115-33. PubMed ID: 1304832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
    Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
    Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p53 mutations occur in aggressive breast cancer.
    Mazars R; Spinardi L; BenCheikh M; Simony-Lafontaine J; Jeanteur P; Theillet C
    Cancer Res; 1992 Jul; 52(14):3918-23. PubMed ID: 1617667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile.
    Wistuba II; Sugio K; Hung J; Kishimoto Y; Virmani AK; Roa I; Albores-Saavedra J; Gazdar AF
    Cancer Res; 1995 Jun; 55(12):2511-5. PubMed ID: 7780959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
    Cote RJ; Jhanwar SC; Novick S; Pellicer A
    Cancer Res; 1991 Oct; 51(19):5410-6. PubMed ID: 1913660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach.
    Tamura G; Sakata K; Maesawa C; Suzuki Y; Terashima M; Satoh K; Sekiyama S; Suzuki A; Eda Y; Satodate R
    Cancer Res; 1995 May; 55(9):1933-6. PubMed ID: 7728762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma.
    Frank TS; Bartos RE; Haefner HK; Roberts JA; Wilson MD; Hubbell GP
    Mod Pathol; 1994 Jan; 7(1):3-8. PubMed ID: 7909153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.